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The P-type ATPases aﬀected in Menkes and Wilson diseases, ATP7A and ATP7B, respectively, are key copper transporters that reg-
ulate copper homeostasis. The N termini of these proteins are critical in regulating their function and activity, and contain six copper-
binding motifs MxCxxC. In this study, we describe the identiﬁcation of glutaredoxin (GRX1) as an interacting partner of both ATP7A
and ATP7B, conﬁrmed by yeast two-hybrid technology and by co-immunoprecipitation from mammalian cells. The interaction required
the presence of copper and intact metal-binding motifs. In addition, the interaction was related to the number of metal-binding domains
available. GRX1 catalyses the reduction of disulphide bridges and reverses the glutathionylation of proteins to regulate and/or protect
protein activity. We propose that GRX1 is essential for ATPase function and catalyses either the reduction of intramolecular disulphide
bonds or the deglutathionylation of the cysteine residues within the CxxC motifs to facilitate copper-binding for subsequent transport.
 2006 Elsevier Inc. All rights reserved.
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ATP7BThe copper-transporting P-type ATPases ATP7A and
ATP7B are critical for regulating systemic copper levels as
demonstrated by the devastating eﬀects seen in patients with
Menkes disease (MD) andWilson disease (WD), respective-
ly [1]. ATP7A is expressed ubiquitously in all tissues except
the liver whereas ATP7B is expressed predominantly in the
liver [2,3]. These proteins actively transport copper to
enzymes within the lumen of the trans-Golgi network
(TGN) and when intracellular copper levels are in excess,
they traﬃc to diﬀerent locations within the cell; ATP7A0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
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E-mail address: sharonl@deakin.edu.au (S. La Fontaine).to the basolateral membrane [4] and ATP7B to subapical
vesicles in which copper is sequestered and eliminated from
the cell via the biliary canalicular membrane [1].
The N-terminal regions of ATP7A and ATP7B are
essential for regulating the catalytic activity and traﬃcking
of these proteins [5,6]. There are six conserved metal-bind-
ing domains (MBD) within an approximately 650 amino
acid N-terminal region. Each domain is approximately 70
amino acids in length and contains one metal-binding site
(MBS, MxCxxC). The six repeating MxCxxC motifs bind
six molar equivalents of copper via the conserved cysteines
and this binding of copper is the means by which they reg-
ulate the copper transport and the copper-responsive redis-
tribution of the ATPases [7,8]. However, the domains are
not functionally equivalent [9] and are between 20% and
60% identical in amino acid sequence. The divergence in
their sequences could suggest that they have additional
distinct roles. In fact most of the metal-binding sites are
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of the ATPases [5,6], and the N-terminal regions may have
roles in addition to copper-binding [10]. There are also
other signals or motifs within the N-terminal region that
potentially direct the copper-induced traﬃcking of ATP7A
and ATP7B [11,12]. In addition, three proteins are now
known to interact with the N terminus of either or both
of the copper ATPases. The copper chaperone ATOX1
interacts with the N termini of both ATP7A and ATP7B
in a copper-dependent manner and this interaction is essen-
tial for copper delivery to the secretory pathway [13,14].
COMMD1 (MURR1) is mutated in Bedlington terrier
dogs to produce a WD-like copper toxicosis [15] and inter-
acts with the N terminus of ATP7B [16] but not with
ATOX1 or ATP7A, a ﬁnding consistent with its proposed
role in copper excretion from the liver. Recently we showed
that dynactin subunit p62 interacts speciﬁcally within the
region between MBS 4 and 6 of the ATP7B N terminus
and we proposed that this interaction plays a role in the
copper-regulated traﬃcking of ATP7B [17]. Copper
homeostasis is a complex process most likely mediated by
a network of protein interactions. Hence, it is likely that
many proteins interact with the ATPases to inﬂuence and
regulate their copper transport and/or traﬃcking activities,
and also represent potential targets for disease-causing
mutations.
To further dissect the regulatory potential of the ATP7B
N terminus (ATP7B-N), we previously employed yeast
two-hybrid screening of a human liver cDNA library using
ATP7B-N as a bait to search for additional interacting
partners [17]. This report focuses on one of the proteins,
glutaredoxin (GRX1), that interacted with both ATP7A
and ATP7B, and is likely to have an essential role in main-
taining the activity of the copper ATPases. GRX1 is a
small cytosolic protein that catalyses the reduction of disul-
phide bridges and in particular is known to be a speciﬁc
and eﬃcient catalyst of protein-SSG deglutathionylation
[18]. In this study we show that GRX1 interaction with
the N terminus of ATP7A and ATP7B required copper
and the CxxC motifs. In addition, the extent of the interac-
tion was related to the number of intact metal-binding sites
available to bind copper and potentially the extent to which
they are saturated with copper. These results suggest that
we have identiﬁed a new and key component of the copper
homeostatic machinery, one that is likely to regulate the
copper-binding and transport activity of the ATPases.Materials and methods
Bacterial, yeast, and mammalian cell strains. Escherichia coli strain
DH10B (F, mcrA, D(mrr-hsdRMS-mcrBC), U80lacZDM15, DlacX74,
deoR, recA1, araD, D(ara,leu)7697, galU, galK, rpsL, endA1, nupG) was
used for the maintenance and propagation of plasmids, and grown in
Luria–Bertani medium (LB) (0.1% (w/v) bactotryptone (Difco), 0.05% (w/
v) yeast extract (Difco), and 0.1% (w/v) NaCl) containing 100 lg/ml
ampicillin for plasmid selection. Saccharomyces cerevisiae strain YGH1
(ura3-25 his3-200 ade2-101 lys-2,801 trp1-901 leu2-3 Canr GAL4-542
gal80-538 LYS2::gal1uas-gal1tata-HIS3 URA3::gal1-lacZ) [19] and trans-formants thereof were maintained at 30 C on standard yeast extract–
peptone–dextrose (YPD) solid or liquid medium (1% yeast extract (Difco),
1% (w/v) tryptone (Difco), 2% (w/v) glucose) [20], or the appropriate
synthetic complete dropout (SD) medium (Q-biogene) for the maintenance
of plasmids, respectively. Copper-limited SD medium was prepared using
yeast nitrogen base without copper sulphate (Q-biogene), and supple-
mented with the appropriate concentration of bathocuproinedisulphonic
acid (BCS) (Sigma). To deplete cells of copper, cultures were passaged for
48 h in BCS-supplemented medium. When copper supplementation was
required, the appropriate concentration of CuSO4 was added and cultures
were incubated for a further 24 h.
Human skin ﬁbroblast cells overexpressing ATP7A (A12-H9) or
ATP7B (WND-16) [21] were maintained in Eagle’s basal medium (BME;
Thermo Trace) supplemented with 10% (w/v) fetal calf serum (Thermo
Trace), 2 mM L-glutamine, 0.2 mM proline, 20 mM Hepes, 0.2% (w/v)
sodium bicarbonate, and Geneticin (400 lg/ml) (Invitrogen). Cultures
were incubated at 37 C in a 5% CO2 humidiﬁed incubator. Copper-lim-
ited medium was prepared by supplementing BME with 100 lM BCS and
100 lM D-penicillamine (Sigma).
Generation of plasmid constructs. To generate a bait construct that
encoded the N terminus of ATP7B (ATP7B-N), a 1971 bp fragment that
encoded amino acids 1 to 657 was ampliﬁed by PCR using pCMB278 [5]
as a template, the forward primer 5 0-ccccatatgATGCCTGAGCAGGA
GAGACAG-3 0 (hWND30) and the reverse primer 5 0-gggcagc
tgCGACGTGTCCTTTCTGAAGAAGGTGAC-3 0 (hWND8) (NdeI and
SalI restriction sites in lowercase, boldface type). The resulting PCR
product was cloned into the NdeI/SalI restriction sites of the pAS2-1
GAL4 DNA-binding domain (BD) vector (Clontech) to create pAS2-1/
ATP7B-N (pSLB10). A 1.8 kb fragment of ATP7A that encoded the N
terminus from amino acid 1 to 600 was cloned as a BamHI/PstI fragment
from pCMB151 [14] into pAS2-1, to create pAS2-1/ATP7A-N (pSLB34).
To create plasmid constructs that encoded mutated or deleted ATP7B
N-terminal regions as baits, PCR was carried out using the forward primer
hWND30 and the reverse primer hWND8 and the following plasmids as
templates [5]: pCMB398 (ATP7B-N with both cysteines within the CxxC
motifs of all six of the metal-binding domains mutated to serine, that is
SxxS); pCMB404 (ATP7B-N with MBS 1–5 deleted); pCMB405 (ATP7B-
N with MBS 4–6 deleted). The PCR products were cloned into the NdeI/
SalI sites of pAS2-1 to create the following plasmids: pAS2-1/MBS1-6c/s
(pSLB96); pAS2-1/MBS1-5del (pSLB97); pAS2-1/MBS4-6del (pSLB98),
respectively.
To produce a construct that encoded an N-terminal c-myc epitope-
tagged GRX1, the full-length GRX1 cDNA was ampliﬁed from the
pACT2/GRX1 library plasmid (pSLB99) using the forward primer 5 0-
gcaaagcttGGCATGGAACAAAAACTCATATCAGAAGAAGACCTG
GCTCAAGAGTTTGTGAA CTGC-30 (GRX1-F1) and the reverse
primer 5 0-tgcggatccTTACTGCAGAGCTCCAATCTGCTT-3 0 (GRX1-
R2) (HindIII and BamHI restriction sites in lowercase, boldface type). The
sequence that encoded the c-myc epitope tag (underlined, amino acid
sequence EQKLISEEDL) was incorporated into the forward primer. The
PCR product was cloned into the pGEM-T Easy vector (Promega).
The GRX1-myc cDNA was then isolated as a HindIII/BamHI fragment
and cloned into the HindIII and BamHI sites of the mammalian expres-
sion vector pcDNA3 (Invitrogen), to create pcDNA3/GRX1-myc
(pSLB101).
Yeast two-hybrid screening. A human liver cDNA library constructed
in the pACT2 GAL4 activation domain (AD) vector (Clontech) was
screened using ATP7B-N as the bait, as previously described [17]. Liquid
b-galactosidase assays using chlorophenol red-b-D-galactopyranoside
(CPRG) (Sigma) as the substrate were performed by following the Clon-
tech protocol (Yeast Protocols Handbook, Clontech, 2000). For each
culture within a single experiment the b-galactosidase activity of triplicate
samples was measured. The values obtained represent b-galactosidase
activity calculated in Miller units using the average value obtained from at
least three independent experiments ± SD.
DNA sequence analysis. Sequencing of plasmid DNA was carried out
using ABI PRISM BigDye Terminator chemistry (Applied Biosystems)
with reactions analysed on an Applied Biosystems 3730S capillary
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University (Melbourne, Australia). Sequence analysis and basic sequence
manipulation were performed using Sequencher (GeneCodes). Electronic
database searches were conducted using the BLASTN and BLASTP
algorithms on the NCBI website (www.ncbi.nlm.nih.gov/BLAST/).
Immunoblot analysis of S. cerevisiae YGH1 transformants. Total pro-
tein extracts from S. cerevisiae YGH1 transformants were prepared using
a TCA extraction method as described in the Yeast Protocols Handbook
(Clontech, 2000). Approximately 50 lg of protein was fractionated by
SDS–PAGE. Proteins were transferred to Hybond-C+ nitrocellulose
membranes (Amersham) using a Trans-Blot semi-dry electrophoretic
transfer apparatus (Bio-Rad) and detected with either sheep-derived,
aﬃnity-puriﬁed NC36 anti-ATP7B antibody (diluted 1:500 [5]), or rabbit-
derived antibodies directed against the GAL4 DNA-BD (ﬁnal concen-
tration 2 lg/ml) (Sigma) or the GAL4 AD (ﬁnal concentration 1 lg/ml)
(Sigma). Secondary antibodies used for detection were a rabbit anti-goat
IgG peroxidase conjugate (Sigma) and a goat anti-rabbit IgG peroxidase
conjugate (Chemicon), respectively. Protein bands were detected after
incubation in Lumi-Light Chemiluminescence blotting substrate (Roche)
and visualised using the Luminescent Image Analyser LAS-3000 (Raytest
Isotopenmessgeraete GmbH).
Mammalian cell transfection and co-immunoprecipitation. Transient
transfection of plasmid DNA into mammalian ﬁbroblast cell lines was
carried out using Lipofectamine (Invitrogen) and recommended
protocols. For co-immunoprecipitation of interacting proteins from
mammalian cells, the ProFound Mammalian Co-Immunoprecipitation
Kit (Pierce) was used according to the manufacturer’s instructions.
Speciﬁcally, 200 lg of the aﬃnity-puriﬁed NC36 anti-ATP7B antibody
[5], 200 lg of the aﬃnity-puriﬁed R17-BX anti-ATP7A antibody [22]
and, as a control, sheep pre-immune serum were covalently immobilised
to the amine-reactive antibody coupling gel. Human Menkes patient
ﬁbroblasts that stably expressed either ATP7A (A12-H9) or ATP7B
(WND-16) [21] were transiently transfected with pcDNA3/GRX1-myc or
left untransfected and grown to conﬂuence in 75 cm2 ﬂasks either in the
absence or presence of the copper chelators BCS (100 lM) and D-peni-
cillamine (100 lM). Cells were lysed and applied to the gel. The protein
complexes were eluted in 50 ll elution buﬀer, boiled in sample buﬀer
with added DTT (20 mM ﬁnal concentration), and fractionated by
SDS–PAGE. Proteins were transferred to Hybond-C+ membrane
(Amersham) using a Trans-Blot semi-dry electrophoretic transfer appa-
ratus (Bio-Rad) and detected with either the NC36 antibody (diluted
1:500 [5]), the R17-BX antibody (diluted 1:1000 [22]), or a rabbit-derived
anti-myc polyclonal antibody (diluted 1:1000 Abcam (ab9106)). The
secondary antibodies used for detection were a rabbit anti-goat IgG
peroxidase conjugate (Sigma) or a sheep anti-rabbit IgG peroxidase
conjugate (Chemicon). Protein bands were detected after incubation in
Lumi-Light Chemiluminescence blotting substrate (Roche) and visualised
using the Luminescent Image Analyser LAS-3000 (Raytest Isotopen-
messgeraete GmbH).
Results
Screening of a human liver cDNA library for interacting
partners of the ATP7B N-terminal domain
A human liver cDNA library was previously screened
with the entire N-terminal domain of ATP7B from amino
acid 1 to 657 [17]. Of 36 diﬀerent cDNAs identiﬁed to
encode interacting proteins one encoded the full-length
GRX1 protein. Based on the presence of the conserved
copper-binding motif, CxxC in GRX1, the well-established
role of GRX1 in regulating the redox status of protein
thiols, in particular its role in reducing intramolecular
disulphide bonds and in deglutathionylating cysteinyl thi-
ols, and the abundance of cysteine residues in the copperATPases, GRX1 seemed a likely candidate to impact on
the activity of the copper ATPases and was selected for fur-
ther detailed analysis. The plasmid contained an insert of
approximately 800 bp of which 321 bp comprised an open
reading frame that encoded the full-length GRX1 protein
(106 amino acids), 54 bp comprised part of the 5 0untrans-
lated region (UTR), and 420 bp comprised part of the
3 0UTR to the start of the polyA tail.
GRX1 interacts with the N terminus of ATP7A and ATP7B
Saccharomyces cerevisiae YGH1 co-transformants were
generated that expressed the full-length GRX1 protein and
either ATP7B-N or ATP7A-N fused in-frame to the DNA-
BD of GAL4. The negative control was a transformant
that contained pAS2-1/ATP7B-N and pACT2. Using a
b-galactosidase activity assay we showed that GRX1 inter-
acted with the N termini of ATP7B and ATP7A, albeit to a
slightly lesser extent with ATP7A (Fig. 1A). The negative
control showed that the positive b-galactosidase result with
ATP7B-N and GRX1 did not arise from interaction with
vector-derived proteins. There was also no interaction
between GRX1 and the unrelated protein Bcl2 (data not
shown). The appropriate fusion proteins were expressed
in all co-transformants, so that the lack of b-galactosidase
activity in the negative control transformant was not due to
lack of protein expression (Fig. 1B).
Co-immunoprecipitation experiments were carried out
using human Menkes patient ﬁbroblast cell lines that stably
expressed either ATP7A (A12-H9) or ATP7B (WND-16)
[21]. In this study, these cell lines were transfected with
pcDNA3/GRX1-myc to transiently express myc-tagged
GRX1. In these experiments, the NC36 antibody precipi-
tated both ATP7B and the myc-tagged GRX1 from cell
lysates, whereas the pre-immune serum did not precipitate
either protein (Fig. 1C). Similarly, the R17-BX antibody
precipitated ATP7A and GRX1-myc from the ATP7A-ex-
pressing cell line (Fig. 1D). We concluded that the interac-
tion between both copper-ATPases and GRX1 represented
true and speciﬁc interactions in mammalian cells.
Copper is required for the interaction between GRX1 and the
ATPases
We demonstrated that copper is required for the interac-
tion between GRX1 and the ATP7B N terminus. S. cerevi-
siae YGH1 that expressed ATP7B-N and GRX1 was
grown for 48 h in medium that was depleted of copper by
the addition of various concentrations of the copper chela-
tor BCS. b-Galactosidase activity assays showed that
100 lM BCS was enough to reduce the interaction by four-
fold (Fig. 2A), and 500 lM BCS almost completely abol-
ished the interaction. We showed previously that the
addition of BCS does not aﬀect the activity of b-galactosi-
dase [17]. Therefore, the reduced interaction in the presence
of BCS cannot be attributed to an eﬀect of BCS on b-galac-
tosidase activity. The addition of 50 lM CuSO4 to the
Fig. 1. Interaction of GRX1 with the N terminus of ATP7A and ATP7B. (A) b-Galactosidase activity of S. cerevisiaeYGH1 co-transformants is shown in
Miller units and using the average value obtained from at least three independent experiments ± SD. (B) Expression of GAL4 DNA-BD and AD fusion
proteins. Panels show the GAL4 DNA-BD and AD fusion proteins (indicated above each lane) that are expressed in each co-transformant as detected with
aﬃnity-puriﬁed GAL4 DNA-BD and AD antibodies (Sigma), respectively. The position of protein molecular weight markers (Fermentas and Bio-Rad)
are shown on the left in kilodaltons (kDa). (C,D) Co-immunoprecipitation of ATP7B or ATP7A and GRX1 from human ﬁbroblast cell lines, WND16 and
A12-H9 [21], respectively, transiently transfected with pcDNA3/GRX1-myc. Samples from the ﬁrst three elutions (Co-IP elution 1, 2, and 3) were
fractionated on SDS–PAGE gels. As controls for protein size and expression, aliquots of untransfected, and pcDNA3/GRX1-myc-transfected cell lysates
also were loaded on each gel. A sample of the eluate from a column prepared with immobilised serum was also loaded and served as a negative control.
Proteins were detected with: (C) (i) NC36 (anti-ATP7B, diluted 1:500) or (ii) ab9106, (anti-c-myc, diluted 1:1000, Abcam), and (D) (i) R17-BX (anti-
ATP7A, diluted 1:1000) or (ii) ab9106 (diluted 1:1000). The sizes of prestained protein molecular weight markers (Fermentas and Bio-Rad) are shown on
the right in kilodaltons (kDa).
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Fig. 2. Copper is required for the interaction between GRX1 and the ATP7B N terminus. Cultures of S. cerevisiaeYGH1 co-transformants that expressed
ATP7B-N and GRX1 were passaged for 48 h in (A) medium supplemented with the copper chelator BCS, or (B) medium supplemented with 500 lM BCS
and CuSO4. b-Galactosidase activity was measured in three independent experiments and values shown represent means ± SD. Panels below the graph
show immunoblots of the GAL4 DNA-BD/ATP7B-N and GAL4 AD/GRX1 fusion proteins that are expressed in each culture represented in the graph,
detected with the GAL4 AD antibody (ﬁnal concentration 1 lg/ml) (Sigma) and NC36 (anti-ATP7B, diluted 1:500 [5]). An image of a portion of the
membrane stained with Ponceau Red demonstrates approximately equivalent protein loading in each lane. (C) The ATP7B/GRX1 interaction is
dependent on copper in mammalian cells. WND-16 ﬁbroblast cells [21] were transiently transfected with pcDNA3/GRX1-myc and then grown for 72 h in
the absence or presence of 100 lM BCS and 100 lM D-penicillamine. Proteins from treated and untreated cell lysates were co-immunoprecipitated from a
column prepared with immobilised NC36 antibodies [5]. Samples (20 ll) from the ﬁrst two elutions (Co-IP elutions 1 and 2) were fractionated on SDS–
PAGE gels. As controls for protein size and expression, aliquots of treated and untreated cell lysates also were loaded on each gel. Proteins were detected
with: (i) NC36 (diluted 1:500 [5]) or (ii) ab9106 (anti-c-myc, diluted 1:1000, Abcam). The sizes of prestained protein molecular weight markers (Fermentas)
are shown on the right in kilodaltons (kDa).
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mal levels (Fig. 2B) but there was a notable reduction in the
extent of the interaction with P100 lM CuSO4. Similarresults were obtained when these experiments were repeat-
ed with the ATP7A N terminus (data not shown). Note
that protein levels were not aﬀected by the variations in
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interaction were not a reﬂection of copper-induced changes
in protein expression (Fig. 2B).
Co-immunoprecipitation experiments conﬁrmed that
copper was required for the ATP7B/GRX1 interaction to
occur. WND-16 cells transfected with pcDNA3/GRX1-
myc to transiently express myc-tagged GRX1 and grown
either in the absence or in the presence of 100 lMBCS plus
100 lM D-penicillamine for 72 h. The NC36 antibody pre-
cipitated both ATP7B and myc-tagged GRX1 from the
cells grown in normal medium (Fig. 2C(i)). However, when
cells were grown in copper-depleted medium there was a
substantial reduction in the amount of GRX1-myc that
was co-precipitated with ATP7B (Fig. 2C(ii)). There was
no diﬀerence in the amount of GRX1-myc or ATP7B pro-
tein in each of the lysates indicating that the BCS/D-penicil-
lamine treatment did not aﬀect the expression levels of
these proteins. We concluded that the reduction in the
amount of GRX1 that was co-precipitated with ATP7B
was due to copper depletion, conﬁrming that copper was
required for the ATP7B/GRX1 interaction in mammalian
cells. Note that concentrations of BCS between 50 lM
and 500 lM have previously been shown to reverse or dis-
rupt the copper-induced traﬃcking of the ATPases [11,23].
The interaction between ATP7B and GRX1 is dependent
upon the CxxC motifs
To investigate the requirement for the CxxC motifs and
the involvement of the diﬀerent MBS within the ATP7B N
terminus in the interaction with GRX1, GAL4 DNA-BD
fusion constructs were generated in which the cysteines in
all six motifs were altered to serines (SxxS) (MBS1-6c/s),
or which contained only metal-binding domain 6 (deleting
amino acids 64–540) (MBS1-5del) or metal-binding
domains 1–3 (deleting amino acids 300–599) (MBS4-6del)
(Fig. 3A). S. cerevisiae co-transformants that expressed
these fusion proteins and GRX1 were assayed for b-galac-
tosidase activity (Fig. 3B). The interaction was negligible
when all six CxxC motifs were mutated to SxxS, clearly
demonstrating a requirement for these motifs for the inter-
action to occur. There was an approximately twofold
reduction in the interaction between GRX1 and MBS4-
6del compared with the wild-type N terminus, suggesting
that the extent of the interaction might be related to the
number of MBDs available for interaction. However,
unexpectedly, there was no detectable interaction between
GRX1 and MBS1-5del. Again, immunoblot analysis of
co-transformants demonstrated expression of all fusion
proteins (Fig. 3C).
A possible explanation for the lack of interaction with
MBS1-5del is that there was suﬃcient copper in normal
medium to eﬃciently saturate the single MBD in all copies
of this truncated protein, but that the yeast two-hybrid sys-
tem was not suﬃciently sensitive to detect the initial inter-
action with GRX1 that would allow copper to bind to this
single site. To test this hypothesis the MBS1-5del/GRX1-expressing co-transformant was grown in medium contain-
ing 500 lM BCS for 48 h to deplete cells of copper, fol-
lowed by supplementation with a range of copper
concentrations (0–500 lM) for 24 h, and then b-galactosi-
dase activity was measured (Fig. 3D). In cells grown in nor-
mal medium, medium with only BCS, and medium
containing BCS and 5 lM copper, the interaction was neg-
ligible. But as the copper content of the BCS-containing
medium increased, the extent of the interaction increased
reaching a maximum level (at 50 lM CuSO4) which was
approximately one-sixth that of the wild-type ATP7B-N/
GRX1 interaction. The interaction decreased with the
addition of 100 lM CuSO4 and was reduced signiﬁcantly
with 500 lM CuSO4. We concluded that GRX1 does inter-
act with MBS1-5del but that this interaction is only detect-
able at a certain level of intracellular copper.
Discussion
The identiﬁcation of interacting partners of the copper
ATPases is important in helping to explain the molecular
and biochemical basis for disease-causing mutations and
for full understanding of the complex mechanisms involved
in copper homeostasis. We have identiﬁed an additional
interacting partner of both ATP7A and ATP7B. GRX1
was chosen as a candidate likely to be implicated in regulat-
ing ATPase activity based on the presence of the conserved
copper-binding CxxC motif within its amino acid sequence,
its role within cells in modulating the redox status of pro-
tein thiols, and the abundance of cysteine residues within
the ATPases. The interaction between GRX1 and the ATP-
ases required copper to be present, and mutation of the cys-
teines to serines in all six CxxC motifs of the metal-binding
domains disrupted the interaction. In the full-length
ATP7B, this mutation disrupted the copper-regulated
redistribution of the protein [5] and its copper transport
activity demonstrating the functional importance of these
cysteines [9]. We concluded that the ATPase/GRX1 inter-
action occurs only when copper is present and the CxxC
motifs are available to coordinate the copper.
Glutaredoxins (GRX) (also called thioltransferases) are
members of the thiol oxidoreductase family of proteins that
catalyse the reduction of protein disulphides to their
respective sulphydryls [24]. Glutaredoxins contain three
functional conserved regions: the active site (CPYC), the
glutathione-binding site sequence, and the hydrophobic
surface area [25]. With their two redox-active cysteines
(CxxC motif), these small proteins are able to catalyse
the reduction of intramolecular disulphide bonds and using
GSH as a cofactor, they can also speciﬁcally reverse pro-
tein-S-glutathionylation (protein-SSG formation) [18,24].
Glutathionylation of cysteine residues within proteins
results in the post-translational formation of a mixed disul-
phide between glutathione and the thiol group of cysteine.
This reversible modiﬁcation is becoming recognised as a
potential regulatory mechanism as well as a protective
mechanism to prevent the oxidation of cysteine residues
Fig. 3. The ATP7B/GRX1 interaction is related to the number of MBS available and requires the CxxC motifs of ATP7B. (A) Schematic illustration of
the ATP7B mutant proteins used in this study. The N-terminal metal-binding domains are shown as ﬁlled boxes. (i) MBS1-6c/s, all of the cysteines in the
CxxC metal-binding motifs altered to serines (SxxS); (ii) MBS1-5del, the ﬁrst ﬁve MBDs deleted; (iii) MBS4-6del, the three most C-terminal MBDs deleted
(B) S. cerevisiae YGH1 co-transformants that expressed GRX1 and fusion proteins that contained these mutations were analysed for b-galactosidase
activity in three independent experiments. Values shown represent means ± SD. Panels below the graph show immunoblots of the fusion proteins that are
expressed in each co-transformant. In the top-right panel the expected protein bands are indicated by an asterisk (*). Proteins were detected with the
GAL4 AD antibody (ﬁnal concentration 1 lg/ml) (Sigma) and NC36 (anti-ATP7B, diluted 1:500 [5]). The position of protein molecular weight markers
(Fermentas and Bio-Rad) is shown on the left in kilodaltons (kDa). (C) The interaction between GRX1 and MBS1-5del is detectable in the presence of a
narrow range of medium copper levels. Cultures of S. cerevisiae YGH1 co-transformants that expressed (i) ATP7B-N and GRX1 and (ii) MBS1-5del and
GRX1 were grown in normal medium. The MBS1-5del/GRX1 co-transformant also was passaged for 48 h in medium supplemented with 500 lM BCS
and CuSO4. b-Galactosidase activity was measured in three independent experiments and values shown represent means ± SD.
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reactions where intramolecular protein disulphides are
reduced by GRX, or monothiol reductions of mixed disul-
phides with GSH. With its glutathione-binding site GRX
preferentially reduces mixed disulphides [27].
The metal-binding sites of ATP7A need to be in a
reduced state for copper to coordinate with the sulphur
atoms on the cysteine residues [28]. The intracellular milieu
is usually a reducing environment due to high concentra-
tions of GSH but reactive oxygen species can alter the
redox balance. Cysteine residues are easily oxidised result-
ing in protein cross-linking and enzyme inactivation [29].
These irreversible oxidation events can be prevented by
protein glutathionylation [30]. With the many cysteine res-
idues within the ATPase N termini and their critical role in
co-ordinating copper as an integral part of ATPase func-
tion, it is feasible that these cysteines are glutathionylated
for protection against irreversible oxidation. Interaction
with GRX1 then would serve to deglutathionylate the cys-
teines when copper is present so that the copper can be
coordinated by the thiol groups. Alternatively, GRX may
act to reduce intramolecular disulphide bonds formed by
the cysteine residues to allow copper coordination by the
thiol groups, prior to copper translocation by the ATPases.
The extent of the interaction with GRX1 was related to
the number of MBS available and possibly their level of
copper saturation. The interaction was reduced by approx-
imately twofold when three MBS (MBS4-6del) were pres-
ent, alluding to the possibility that the interaction
between individual metal-binding sites and GRX1 is func-
tionally equivalent.
Initially and unexpectedly there was no detectable
interaction between the MBS 1-5del mutant protein and
GRX1 in cells grown in normal medium. However, when
copper was depleted from the medium then replenished in
increasing amounts, an interaction became apparent and
peaked at a level that was approximately one-sixth that
of the wild-type ATP7B-N/GRX1 interaction. As the cop-
per content of the medium was increased further
(P100 lM), the interaction decreased. A similar pattern
of interaction was evident with the wild-type ATP7B-N/
GRX1 interaction that also was substantially reduced
with the addition of excess copper (P100 lM). The rea-
son for this decrease in the interaction with excess copper
is not clear but one possibility is that there is a saturation
eﬀect so that once copper is bound by the MBS, in this
system there is subsequently a reduced need for interac-
tion with GRX1. Note that the MBS1-5del mutation in
the full-length protein could still traﬃc as wild-type
ATP7B [5] and transport copper [9], consistent with its
ability to bind copper.
Together these results suggest that the interaction with
GRX1 is not speciﬁc to any particular metal-binding
domain, but that each MBS is equivalent with respect to
its interaction with GRX1. This suggestion is consistent
with the general role of GRX1 in the cell in regulating
the redox status of cysteinyl thiols as part of a protectivemechanism and/or to regulate protein activity. In this con-
text it is feasible that GRX1 could also interact with other
cysteine-containing copper-binding proteins such as
ATOX1, COX17, CCS, and SOD1.
We propose that the ATPase/GRX1 interaction occurs
based on copper levels and need. When intracellular copper
levels are low, the cysteine residues of the ATPase CxxC
motifs are protected from irreversible oxidation either by
intramolecular disulphide bond formation or by glutath-
ionylation. In this state, there is little need for GRX1 inter-
action. When intracellular copper levels increase then the
CxxC motifs need to be in a reduced state to accept the
metal. GRX1 then interacts with the CxxC motifs when
copper is present to deglutathionylate the cysteines or to
reduce intramolecular disulphide bonds, thus allowing cop-
per to bind to the ATPases for subsequent transport. When
intracellular copper is suﬃcient or in excess and the MBS
of the ATPases are fully occupied by copper, again the
need for interaction with GRX1 is eliminated. This model
is consistent with our results that demonstrated a require-
ment for copper and intact cysteine residues in order for
the GRX1/ATPase interaction to be detected.
Copper binding to the ATPase N termini is essential to
their function in translocating copper across cell mem-
branes [9,31]. Therefore, it is feasible that GRX1 is essen-
tial for their activity in its capacity to facilitate copper
binding by the CxxC motifs. This possibility is supported
by the fact that both ATPases interact with GRX1 to a
similar extent and that these interactions require copper.
The identiﬁcation of GRX1 as an interacting partner of
the ATPases represents a signiﬁcant discovery of a mole-
cule whose function is likely to prove integral to the activity
of the ATPases, and will provide further insight into the
molecular mechanisms that regulate cellular copper
homeostasis.
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